Benchmark Maintains Speculative Buy on CapsoVision, Lowers Price Target to $10
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowers the price target from $14 to $10.
Benchmark analyst Bruce Jackson maintains CapsoVision (NASDAQ:CV) with a Speculative Buy and lowers the price target from $14 to $10.